Key Assessment and Evaluation Strategies After CAR T-Cell Therapy

Key Assessment and Evaluation Strategies After CAR T-Cell Therapy is organized by National Comprehensive Cancer Network (NCCN) and will be held from Dec 15, 2022 - Dec 15, 2023.,,Description:,CAR T-cell therapy is becoming more widely available and more frequently used given the availability of commercial CAR T-cell products and the approvals of multiple agents in the last 2-3 years. This presents a unique set of issues surrounding the assessment and management of patients outside of clinical trials in community settings. The management of adverse effects, including toxicity from treatment as well as the education of patients and the coverage of these treatments by insurance are imperative to good clinical care of patients receiving these therapies.,,Learning Objectives:,Following this activity, participants should be able to:,• Define CAR T-cell therapies and their uses in clinical practice. ,• Describe the mechanism of action in the treatment of disease and how this relates to adverse effects. ,• Understand the assessment and strategies for the prevention and management of CAR T-cell adverse events.,,Additional details will be posted as soon as information is available.